A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.

NCT04642365 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
49
Enrollment
INDUSTRY
Sponsor class

Stopped The sponsor decided to terminate the study early, due to recruitment challenges for Part II and, based on the totality of data generated with a low likelihood of achieving the targeted efficacy, to open Part III.

Conditions

Interventions

Sponsor

Hoffmann-La Roche